| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0004 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |